Trademark search for:

AGE MANAGEMENT THERAPEUTICS

EXPIRED USPTO USPTO

USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2003-06-12 — Application filed
2003-12-16 — Assigned to examiner
2003-12-18 — Final disposition recorded
2004-04-22 — Teas change of correspondence received
2004-06-08 — Paper received
2004-06-08 — Amendment from applicant entered
2004-06-08 — Correspondence received in law office
2004-06-29 — Paper received
2004-07-14 — Approved for registration supplemental register
2004-07-14 — Examiners amendment e-mailed
2004-09-21 — Registered-supplemental register
2004-11-22 — Paper received
2004-11-22 — Sec 7 request filed
2005-07-22 — Paper received
2006-03-21 — Review of correspondence complete
2010-03-03 — Automatic update of assignment of ownership
2010-03-03 — Teas section 8 received
2010-03-10 — Case assigned to post registration paralegal
2010-03-10 — Registered - sec. 8 (6-yr) accepted
2011-03-08 — Attorney/dom.rep.revoked and/or appointed
2011-03-08 — Teas revoke/app/change addr of atty/dom rep received
2015-04-24 — Cancelled sec. 8 (10-yr)/expired section 9
2015-04-24 — Final status recorded

Owner Information

UNIFUND CORPORATION
BEVERLY HILLS , CA

UNIFUND CORPORATION LIMITED
LONDON E1 6EU GB

UNIFUND CORPORATION LIMITED
LONDON E1 6EU GB

Nathan Sassover
Los Angeles , CA

Correspondent

Nathan Sassover
9301 Wilshire Blvd, Suite 300
Beverly Hills, CA 90210
UNITED STATES

Filing Details

Filing Date:
2003-06-12

Status Date:
2015-04-24

Category:
Pharmaceuticals

Filing Year:
2003

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.